| Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth Y Shao, SC Forster, E Tsaliki, K Vervier, A Strang, N Simpson, N Kumar, ... Nature 574 (7776), 117-121, 2019 | 817 | 2019 |
| Identification of bacteria-derived HLA-bound peptides in melanoma S Kalaora, A Nagler, D Nejman, M Alon, C Barbolin, E Barnea, ... Nature 592 (7852), 138-143, 2021 | 245 | 2021 |
| Large-scale machine learning for metagenomics sequence classification K Vervier, P Mahé, M Tournoud, JB Veyrieras, JP Vert Bioinformatics 32 (7), 1023-1032, 2016 | 94 | 2016 |
| Two microbiota subtypes identified in irritable bowel syndrome with distinct responses to the low FODMAP diet K Vervier, S Moss, N Kumar, A Adoum, M Barne, H Browne, A Kaser, ... Gut 71 (9), 1821-1830, 2022 | 90 | 2022 |
| The Mouse Gastrointestinal Bacteria Catalogue enables translation between the mouse and human gut microbiotas via functional mapping BS Beresford-Jones, SC Forster, MD Stares, G Notley, E Viciani, ... Cell host & microbe 30 (1), 124-138. e8, 2022 | 73 | 2022 |
| Host adaptation in gut Firmicutes is associated with sporulation loss and altered transmission cycle HP Browne, A Almeida, N Kumar, K Vervier, AT Adoum, E Viciani, ... Genome Biology 22, 1-20, 2021 | 40 | 2021 |
| Functional microbiomics reveals alterations of the gut microbiome and host co‐metabolism in patients with alcoholic hepatitis B Gao, Y Duan, S Lang, D Barupal, TC Wu, L Valdiviez, B Roberts, ... Hepatology Communications 4 (8), 1168-1182, 2020 | 36 | 2020 |
| The MITRE trial protocol: a study to evaluate the microbiome as a biomarker of efficacy and toxicity in cancer patients receiving immune checkpoint inhibitor therapy NA Thompson, GD Stewart, SJ Welsh, GJ Doherty, MJ Robinson, ... BMC cancer 22 (1), 99, 2022 | 19 | 2022 |
| Benchmark of structured machine learning methods for microbial identification from mass-spectrometry data K Vervier, P Mahé, JB Veyrieras, JP Vert arXiv preprint arXiv:1506.07251, 2015 | 16 | 2015 |
| Whole-genome sequencing in a family with twin boys with autism and intellectual disability suggests multimodal polygenic risk B McKenna, T Koomar, K Vervier, J Kremsreiter, JJ Michaelson Molecular Case Studies 4 (6), a003285, 2018 | 14 | 2018 |
| Identification Of Microorganisms By Spectrometry And Structured Classification K Vervier, P Mahe, JB Veyrieras US Patent App. 14/387,777, 2015 | 14 | 2015 |
| MetaVW: Large-scale machine learning for metagenomics sequence classification K Vervier, P Mahé, JP Vert Data Mining for Systems Biology: Methods and Protocols, 9-20, 2018 | 11 | 2018 |
| SLINGER: large-scale learning for predicting gene expression K Vervier, JJ Michaelson Scientific reports 6 (1), 39360, 2016 | 10 | 2016 |
| Genetic and morphological estimates of androgen exposure predict social deficits in multiple neurodevelopmental disorder cohorts BG McKenna, Y Huang, K Vervier, D Hofammann, M Cafferata, ... Molecular autism 12 (1), 43, 2021 | 7 | 2021 |
| TiSAn: Estimating Tissue Specific Effects of Coding and Noncoding Variants. K Vervier, M Jacob J. Bioinformatics, 2018 | 7 | 2018 |
| On learning matrices with orthogonal columns or disjoint supports K Vervier, P Mahé, A d’Aspremont, JB Veyrieras, JP Vert Machine Learning and Knowledge Discovery in Databases: European Conference …, 2014 | 7 | 2014 |
| Functional and taxonomic comparison of mouse and human gut microbiotas using extensive culturing and metagenomics BS Beresford-Jones, SC Forster, MD Stares, G Notley, E Viciani, ... bioRxiv, 2021.02. 11.430759, 2021 | 6 | 2021 |
| CarboLogR: a Shiny/R application for statistical analysis of bacterial utilisation of carbon sources K Vervier, HP Browne, TD Lawley bioRxiv, 695676, 2019 | 5 | 2019 |
| Precision microbiome profiling identifies a novel biomarker predictive of Immune Checkpoint Inhibitor response in multiple cohorts and a potent therapeutic consortium of bacteria MJ Robinson, K Vervier, S Harris, R Rabbie, D Milne, C Booth, ... Cancer Research 81 (13_Supplement), 1783-1783, 2021 | 2 | 2021 |
| Using precision microbiome profiling to develop a biomarker for immune checkpoint inhibitor response and a novel therapeutic. M Robinson, K Vervier, A Popple, S Harris, R Hudson, D Adams, ... Journal of Clinical Oncology 39 (15_suppl), e21546-e21546, 2021 | 2 | 2021 |
Trevor D LawleyWellcome Trust Sanger Institute在 sanger.ac.uk 的电子邮件经过验证
